Effects of Moclobemide, a New Generation Reversible Mao-A Inhibitor, in a Novel Animal Model of Depression
The DOI matches its Crossref record.
Abstract
This study was designed to investigate the predictive validity of a recently described chronic mild-stressinduced anhedonia model of depression. In an intracranial self-stimulation (ICSS) paradigm, rats were allowed to selfstimulate in the ventral tegmental area. Stimulation frequency thresholds for ICSS responses were determined prior to, during, and after a 19-day period of exposure to a variety of mild, intermittent, unpredictable stressors. After nine days of mild stress, stimulation threshold was significantly increased, suggesting a gradual decrease in the rewarding properties of brain stimulation. This anhedonic state lasted throughout the stress period and slowly disappeared over a 10-day period after termination of the stress regimen. This stress-induced increase in ICSS threshold was not observed in rats that were stressed and concomitantly treated with the reversible inhibitor of monoamine oxidase type A (RIMA) moclobemide (20 mg / kg, b.i.d.). In nonstressed animals treated with vehicle or moclobemide, no significant change in ICSS occurred during the course of the experiment. These experimental results reinforce the value of this animal model with respect to its predictive and construct validity. Zusammenfassung Diese Studie prüft die prognostische Gültigkeit eines neuen Depressionsmodells, das auf einer durch wiederholten, milden Streß erzeugten Anhedonia beruht. In einem Hirn-Selbstreizungs-Paradigma konnten sich Ratten über eine Elektrode im ventralen Tegmentum elektrisch stimulieren. Die Frequenzschwellen wurden vor, während und nach einer 19 tägigen Periode gemessen, in der die Ratten verschiedenen kurzen, milden und unvorhergesehenen Streßbedingungen ausgesetzt wurden. Nach 9 Tagen milder Streßexposition war die Reizschwelle signifikant erhöht, was auf eine graduelle Abschwächung der Belohnungseigenschaften der Hirnreizung hindeutet. Dieser anhedonische Zustand dauerte während der ganzen Streßperiode und verschwand danach langsam während der nachfolgenden 10 Tage. Diese Streß-induzierte Reizschwellenerhöhung trat nicht auf, wenn die Tiere gleichzeitig mit dem reversiblen Monoaminoxidase-Hemmer des Typs A (RIMA) Moclobemid (20 mg / kg bid) behandelt wurden. Bei nicht gestreßten Tieren bewirkte Moclobemid keine signifikante Veränderung der Hirnselbstreizungsschwelle. Diese Versuchsergebnisse untermauern den Nutzen dieses Tiermodells im Hinblick auf seinen prognostischen Wert und seine Relevanz für die Depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
“These studies demonstrate that CMS does not cause a generalized attenuation of motivated behaviours, but rather, a specific impairment of rewarded behaviours.The majority (eight) of the research groups represented in table 2 have reported that these other ‘anhedonic’ effects of CMS were reversed or prevented by chroni…”
BackgroundThe chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959
Jayatissa, M. N., Bisgaard, C., Tingström, A., Papp, M., & Wiborg, O. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301041 · Cited by 348
Animal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
D'Aquila, P. S., Brain, P., & Willner, P. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90316-6 · Cited by 322
Willner, P., Moreau, J.-L., Kurre Nielsen, C., Papp, M., & Sluzewska, A. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02256-2 · Cited by 205
Self-citation
Metadata
- Authors
- Moreau, J., Jenck, F., Martin, J., Mortas, P., & Haefely, W.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 1993-01
- Volume
- 26
- Issue
- 01
- Pages
- 30-33
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2093175570
- Cited by
- 56
- References
- 0
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.